It is so cheap at these levels. It has a decent balance sheet, but trades at 5 times earnings. The problem is auto sales are heading lower globally, he thinks. If you have patience sit tight, but he is loath to get in front of a freight train coming out of the tunnel -- lots of light, but don't get run over.

The stock is very cheap, trading down to book value -- historically a great buy. It bought Aetna and a lot of goodwill. He applies a test on the return on equity and if it is above 10%, then the goodwill is of good value. CVS-N has a ROE of 14%. Yield 3.52%. (Analysts’ price target is $71.69)

He thinks this could soar if stock values go down. The VIX ETF for market volatility is suggesting investors think this market is going up forever. This is a contrarian trade. Do not hold this for a year, it is a trade.

He thinks you should hold higher levels of cash. You should have about 10-20% weighting here now.

Diversity is key. Large biotech has been beat up. Speculation that Novartis is a competitor, but it's at early stages for them. REGN does have a drug for a niche market. Correction is in part because of Novartis speculation plus medicare reimbursement. Current multiple around 13x, you can buy it, but buy it in a basket.

A long-term play. Low EPS growth of about 3.5-4%. Very large company. Don't have a lot of drugs that have exposure over 10%, except Prevnar. Not his favourite growth position. Diversity of assets. Need to do some M&A. Stable dividend. Only paying 15x. You can hold on to this.